Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years).

Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years). Leuk Lymphoma. 2007 Jan; 48(1):65-71.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.